CTNNB1 and neoplasm: Nevertheless, a further study of CTNNB1-mutated NSCLCs reported a heterogeneity of aberrant β-catenin staining within the same tumor, which casts doubt on the efficacy of β-catenin IHC as a predictor of a CTNNB1 mutation in NSCLC [24].